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Introduction
Mammary gland development occurs in two morphogenet-
ically distinct phases. The first begins with the differentia-
tion of a mammary ductal rudiment from the embryonic
epidermis and ends after puberty with an elegant arbo-
rated system of ducts (Fig. 1a). In the second phase,
beginning with pregnancy, acinar milk-secretory lobules
develop on this primary framework. This review focuses on
organotypic branching morphogenesis as it occurs during
the ductal, as opposed to the lobular, phase, because it is
during ductal development that stromal influences are
demonstrably the most crucial to organogenesis. In addi-
tion, more than 90% of human mammary carcinomas are
ductal in origin and it is becoming increasingly clear that
the subversion of reciprocal signals between parenchyma
and stroma are an important aspect of tumor progression.
Finally, although reference will be made to the influence of
the embryonic stroma, called the mesenchyme, on
mammary development, the emphasis will be on postnatal
events because these arguably have a more direct bearing
on breast cancer.
Mammary ducts grow through a complex
stroma
By parturition, the mammary stroma comprises multiple cel-
lular and acellular elements. In the mouse, which is the most
thoroughly studied model and the focus of this review,
adipocytes are the most abundant cell type, followed by
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fibroblasts, various migratory blood cells, endothelial cells
(blood vessels), and nerve cells. Acellular elements include
fibrous and non-fibrous collagens, proteoglycans, and gly-
coproteins, all of which provide mechanical support to the
tissue as well as forming a dynamic, developmentally active
extracellular matrix/basal lamina complex at the
epithelial–stromal boundary (Fig. 1b) [1••]. This complex
connective tissue is found in the mammary glands of differ-
ent species with various ratios of fibrous to fatty elements
[2], and it is within this matrix that mammary ducts elon-
gate, arborate, and, finally, terminate growth (Fig. 1a).
The mammary gland pictured (Fig. 1) is a snapshot of the
situation in adolescence, roughly midway in the ductal
phase of organogenesis. End buds, the highly mitotic
ductal growth points (Fig. 2a), are in the process of elon-
gating by penetrating the fatty stroma; some can be seen
bifurcating. Others that are approaching the edge of the
fat pad (at the right of the image) are in various stages of
terminating (getting smaller) or have ceased to grow alto-
gether (blunt-tipped structures). During this period of
maximum ductal elongation, more than 95% of the gland
is growth-quiescent, maintaining the open spaces
between ducts (Fig. 1a). A prominent, epithelium-induced
modification of the periductal stroma is also noteworthy.
Type I collagen-rich fibrous connective tissue begins to
ensheath the end bud on its flank, roughly at the point in
which it begins to constrict to ductal dimensions (Figs 1b
and 2a). This sheath, which also comprises the basal-
lamina/extracellular matrix complex, is retained and forms a
fibrous sleeve around the subtending duct.
At this point in its development, then, the signature features
of the gland are the following: (1) ductal as opposed to
lobular morphology; (2) large, open spaces between ducts;
(3) most active growth focused in end buds; (4) regressed
end buds at the edge of the fat pad. A role for the stroma in
defining each of these glandular features is supported by
experimental evidence that is discussed below.
Stromal signals determine ductal morphology
In seminal experiments by Kratochwil and Sakakura,
mammary parenchyma was shown to possess a develop-
mental plasticity that is constrained and directed by the
stroma [3••]. When Kratochwil cultured a composite of
embryonic mammary epithelium and embryonic sub-
Figure 1
Ducts and end buds in the juvenile mouse mammary gland.
(a) Photomicrograph illustrating the mammary ductal system in a
5-week-old nulliparous mouse. Note the ‘open’ ductal architecture,
which leaves 80% or more of the gland parenchyma-free. End buds
(large arrows) identify growing ducts. Those end buds that are arrayed
along the right-hand side of the gland are in various stages of
regression. Blunt-tipped branches (small arrows) mark growth-
quiescent ducts. The nipple (asterisk) is at base of the gland.
Magnification approximately ×15. (b) Photomicrograph of a
longitudinal section through an end bud and subtending duct. The
induction of a fibrous connective tissue sheath (large arrows)
coincides with the constriction of the end bud to ductal dimensions.
The alcian blue stain used in this preparation detects
glycosaminoglycans and highlights the extracellular matrix/basal lamina
complex at the epithelial–stromal interface (small arrows) [19].
Magnification ×250.
Figure 2
Photomicrographs illustrating patterns of DNA synthesis in an end bud,
its immediately subtending duct, and a lateral branch (a), as well as in
a duct distant from the growth front (b). [3H]Thymidine
autoradiographs were stained with alcian blue. Large arrows, fibrous
sheath around end bud; small arrows, DNA synthetic cells.
Magnification ×250.Breast Cancer Research    Vol 3 No 4 Silberstein
mandibular (salivary) mesenchyme, the mammary tissue
developed salivary gland-like lobules. Extending these
experiments  in vivo, Sakakura demonstrated that not only
embryonic but also adult mammary tissue could respond
in this way to salivary mesenchymal signals. Importantly,
the instructive properties of the stroma did not extend to
cytodifferentiation: in a pregnant host animal, salivary-like
mammary transplants synthesized the milk protein a-lactal-
bumin. Interestingly, fetal mammary mesenchyme grafted
into the adult gland accelerated tumorigenesis, providing
an early indication that modifications of stromal signaling
could influence the progress of neoplasia.
Open glandular architecture depends on signals from
the periductal stroma
The absence of extensive ductal side branching and infill-
ing of interductal spaces is not due to the terminal differen-
tiation of ductal cells. Even the smallest fragment of a duct,
when transplanted to stroma devoid of parenchyma, under-
goes aggressive growth and can fill a fat pad with a mor-
phologically and functionally complete ductal system. This
capacity is attributed to up to three populations of
mammary stem or progenitor cells [4] and is subject to
stromal inhibition. When similar fragments are transplanted
into a space between existing ducts the graft is maintained
but does not grow (Daniel, unpublished data). Normal inhi-
bition of ductal branching must therefore overcome a
stromal background that is strongly stimulatory; there is
now excellent evidence that transforming growth factor-bs
(TGF-bs), acting in part on stromal targets, are responsible.
The rapid and reversible inhibition of end bud growth by
experimentally implanted TGF-b1 demonstrates the mam-
motrophic activity of this growth factor, whereas its nor-
mally high concentration in the periductal extracellular
matrix and its localized loss over lateral buds strongly
implies an action that modulates secondary ductal growth
[5]. Studies with transgenic mice overexpressing a consti-
tutively activated form of TGF-b1 [6], as well as function-
ablating mutant TGF-b signaling receptors, were
confirmatory. The ectopic expression of TGF-b1 resulted in
a significant decrease in lateral branching, and mutant
TGF-b receptors expressed in the stroma increased lateral
branch infilling [7••]. Because the latter are an important
site of TGF-b action, normal chronic inhibition of branch-
ing must depend, in part, on TGF-b-regulated secondary
signals. Recently, hepatocyte growth factor (HGF), which
can stimulate the branching of mammary epithelial tubes
in vitro and is negatively modulated by TGF-b, has
emerged as a candidate secondary signal [8]. In this
model, TGF-b inhibits branching through the inhibition of
HGF expression in the periductal stroma (reviewed in this
issue). However, the protean effects of TGF-bs on mitoge-
nesis and extracellular matrix dynamics in mammary tissue
make the assignment of any single, TGF-b-mediated
mechanism premature [5].
Ductal elongation and branching depend on
parenchyma-induced modifications of the
periductal stroma
End bud growth
It is striking that ductal growth is so exquisitely focused in
the end buds. The impression that precisely localized, as
opposed to general, signals guide this development is
unavoidable. In fact, this impression is correct and epithe-
lium-induced changes develop the growth-promoting
potential of the stroma immediately in front of end buds.
Exciting new evidence demonstrates that migratory white
blood cells, macrophages and eosinophils, are drawn to
the vicinity of the end bud by chemoattractants and, sur-
prisingly, prove to be essential for the normal development
of end buds [9••]. Interestingly, extensive DNA synthesis in
the stroma around end buds accompanies this activity,
indicating that new stromal cells are not only recruited to
the vicinity of the end bud but are also induced by it to
proliferate [10]. The absence of stromal DNA synthesis
around growth-terminated ducts emphasizes that these
inductive signals are growth-related and are not due
merely to the presence of epithelium.
Steroid autoradiographic experiments have demonstrated
that estrogen receptors are concentrated in the nuclei of
stromal cells around end buds but not in rapidly dividing
cap cells (a stem cell layer covering the tip of the end
bud), indicating a paracrine mechanism [11]. This was
confirmed when estrogen receptor knockout (ERKO)
mice were used to investigate whether the steroid acts
on epithelial or stromal targets. Cunha et al [12] surgi-
cally transplanted ERKO epithelium in combination with
either ERKO or wild-type stroma under renal capsules in
athymic mice and demonstrated that, whereas wild-type
stroma supported organotypic growth of the ERKO
epithelium, no ductal growth was seen with wild-type
epithelium in ERKO stroma. It has been suggested that
estrogen receptors are uniquely concentrated around end
buds, but this has not been proved [11], leaving open the
possibilities that elongating ducts stimulate the induction
of estrogen receptors in nearby stromal cells, attract
estrogen receptor-positive stromal cells, or stimulate their
proliferation. In addition to estrogen, other ductal mam-
mogens act through intermediaries generated in the
stroma (reviewed in this issue and in [13•]). These include
epidermal growth factor, activins/inhibins, and growth
hormone, which stimulates the synthesis of insulin-like
growth factor. Growth stimulatory stromal–epithelial inter-
actions are shown diagrammatically in Fig. 3.
Ductal morphogenesis
Organotypic development depends on two obvious struc-
tural modifications of the end bud, its constriction into a
tube and its bifurcation. Preceding either, there is focal
induction by the end bud of type I collagen-rich connective
tissue and extracellular matrix on its flank (Fig. 1b) and inthe clefts that indent the tip when two new end buds form
(not shown). An active role for collagen in shaping the
duct is indicated. In vitro, mammary epithelial cells embed-
ded in collagen gels form narrow tubules that are also
seen in vivo when fragments of duct form similar tubules
in a bolus of injected type 1 collagen (reviewed in [13•]).
Mechanistically, by binding to members of the integrin
family of extracellular matrix receptors, collagen can stimu-
late the formation of actin-cytoskeletal foci that are
capable of changing mammary cell shape [14]. Indeed, b1-
integrin was localized at the basal surfaces of the end bud
epithelium, and function-blocking antibodies against b-
integrin, as well as antibodies against laminin, reversibly
inhibited end bud development in vivo, while blocking
tubulogenesis  in vitro [15].
The molecular signals governing the sites of fibrous induc-
tion are largely unknown; however, TGF-bs seem likely to
have a role. The experimental release of TGF-b1 in the
vicinity of an end bud by plastic implants caused epithe-
lium-dependent induction of a fibrous connective tissue
cap over the end bud tip. The molecular composition of
this cap reflected that of the fibrous connective tissue on
the flank of the end bud and in developing clefts before
bifurcation, suggesting that TGF-b1 might be the normal
inducer [16].
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Figure 3
Diagrams depicting stromal–epithelial signaling affecting mammary ductal growth and its inhibition. (a) Growth stimulatory signals. Endocrine
mammogens [estrogen (E), growth hormone (GH)], acting on stromal targets in front of the end bud, stimulate the synthesis of the local
mammogens epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), and members of the activin/inhibin family. From the end bud,
unknown retrograde signals (broken lines) stimulate vicinal DNA synthesis and attract macrophages and eosinophils. The stimulation of lateral
branches along mature ducts involves the focal loss or inactivation of transforming growth factor-b1 (TGF-b1), relieving the inhibition of hepatocyte
growth factor (HGF) synthesis and permitting lateral branch development. Outer shaded zone, fibrous sheath; L, lumen. (b) TGF-b in growth
inhibition and induction of the periductal fibrous sheath. Although end buds are inhibited by exogenous TGF-b, it remains unproven as the natural
mechanism for end bud growth termination. In a purely speculative model for fibrous induction, TGF-b, acting in a paracrine mode on
cap/myoepithelial cells (black layer), induces parathyroid-hormone-related protein (P). Secreted parathyroid-hormone-related protein then acts on
stromal targets, inducing highly localized fibrosis. Finally, along the duct, TGF-b1 inhibits lateral branching by blocking HGF action.More recently, parathyroid-hormone-related protein
(PTHrP) has been shown to be crucial for normal ductal
development. Transgenic animals overexpressing the
peptide show severe impairment of ductal extension and
branching [17]. Pertinent to this discussion, PTHrP synthe-
sis is concentrated in the cap cells of end buds and their
myoepithelial descendents on the flank, whereas cognate
receptors seem to be concentrated in the immediately
adjacent fibrous tissue. This indicates a potential role in
stromal induction. With this in mind, the fact that TGF-b
can positively regulate PTHrP is interesting [17] because
TGF-b is present, often at high levels, in the end bud [18]
(Fig. 3b). These observations suggest that TGF-bs might
indirectly cause the induction of the fibrous sheath of end
buds and that experiments to investigate whether PTHrP
induces fibrosis and whether TGF-b1 normally regulates
PTHrP during ductal development would be fruitful.
Inhibition of end bud growth
A combined role for TGF-b-induced fibrous stroma in
inhibiting end bud growth while guiding morphogenesis has
been suggested [5]. Consistent with this hypothesis is the
observation that fibrous connective tissue on the flank pro-
gressively advances to envelop the tips of end buds that are
in the process of stopping growth [19]. Arguing against the
matrix as a primary growth inhibitor, however, implanted
TGF-b inhibits DNA synthesis up to 12 h before the appear-
ance of the fibrous cap. Furthermore, surprisingly high levels
of DNA synthesis can be detected in matrix-ensheathed,
growth-quiescent ducts, some quite distant from the end
bud (Fig. 2). Although this DNA synthesis might or might not
be related to mitosis [20], it nevertheless demonstrates that
growth-stimulatory signals can be quite active in ducts
beneath an intact fibrous stromal sheath. Even though it is
clear that stromal signals must ultimately inhibit end bud
growth [how else can their regression before reaching the
limits of the fat pad be explained (Fig. 1a)?], their identity
remains unknown (Fig. 3b).
Resolving signaling between epithelium and
stroma
During the past decade, classic mammary tissue recombi-
nation experiments have been recalled to duty, this time
using tissue from genetically engineered mice, and have
led to important insights into the stromal origins of ductal
mammogenic signals. Much less is known about the
epithelial signals that reorganize the periductal stroma
and, as I have discussed briefly above, these retrograde
signals are crucial to the realization of the morphogenetic
and growth-promoting potential of the stroma.
Identifying the relevant epithelial signals and placing them
in a proper temporal order with regard to the elicitation of
stromal signals and the ensuing morphogenetic events is
now a major challenge that will require new conceptual as
well as experimental tools. The strong evolutionary conser-
vation of reciprocal, epithelial–stromal signaling in branch-
ing morphogenesis, which encompasses the development
of branched airways from insects to mammals, for
example, suggests that careful study of these systems
could provide new ideas pertinent to mammary growth
and morphogenesis [21••].
Conclusion
In an earlier review [13•] I suggested that bringing modern
molecular methods to bear to investigate the dynamics of
gene expression in the stroma and epithelium at obvious
growth and morphogenetic inflection points (eg in front of
end buds) would be useful. However, this approach does
not address the vital issue of the temporal order of signal-
ing, the resolution of which would benefit from a ‘time-
zero’ experimental condition, in which growth-static
mammary ducts could be induced to grow in a controlled
manner. Although there should be several ways of accom-
plishing this, simple ductal transplants come first to mind.
Through an analysis of the initiation and earliest phases of
transplant outgrowth over a finely spaced time-course, it
might be possible to obtain an orderly reading of recipro-
cal epithelial and stromal signals that underlie stromal
reorganization and ductal extension.
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